Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $19,308 - $32,888
101 Added 2.14%
4,811 $1.57 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $205,423 - $275,220
1,276 Added 37.16%
4,710 $897,000
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $92,889 - $135,737
-478 Reduced 12.22%
3,434 $683,000
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $25,204 - $34,202
113 Added 2.97%
3,912 $1.12 Million
Q1 2023

May 12, 2023

BUY
$175.41 - $217.92 $8,244 - $10,242
47 Added 1.25%
3,799 $823,000
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $37,810 - $54,911
185 Added 5.19%
3,752 $771,000
Q3 2022

Nov 10, 2022

BUY
$195.21 - $310.53 $696,314 - $1.11 Million
3,567 New
3,567 $992,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.